# OnCo record henlius (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/henlius/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "henlius" ;
  schema:name "Shanghai Henlius Biotech"@en ;
  schema:description "Chinese biosimilar and biologics company whose PD-1 antibody serplulimab is approved in China and Europe for small-cell lung cancer."@en ;
  schema:url <https://onco.cc/companies/henlius/>, <https://www.henlius.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.henlius.com> ;
  onco:tag "china" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/sclc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/serplulimab/>, <https://onco.cc/drugs/trastuzumab-biosimilars/>, <https://onco.cc/drugs/hlx43/>, <https://onco.cc/drugs/hlx22/>, <https://onco.cc/drugs/hlx11/>, <https://onco.cc/drugs/hlx26/> ;
  onco:trials <https://onco.cc/trials/astrum-005/>, <https://onco.cc/trials/nct05353257/>, <https://onco.cc/trials/nct04547166/>, <https://onco.cc/trials/nct05468489/>, <https://onco.cc/trials/nct06769152/>, <https://onco.cc/trials/nct07253142/>, <https://onco.cc/trials/nct07269782/>, <https://onco.cc/trials/nct06848699/>, <https://onco.cc/trials/nct06839066/>, <https://onco.cc/trials/nct07294508/>, <https://onco.cc/trials/nct06769113/>, <https://onco.cc/trials/nct06349980/>, <https://onco.cc/trials/nct07106892/>, <https://onco.cc/trials/nct06812260/>, <https://onco.cc/trials/nct06742892/>, <https://onco.cc/trials/nct05787613/>, <https://onco.cc/trials/nct06907615/>, <https://onco.cc/trials/nct06832202/> .